Valuation: Lead Data Inc.

Market Cap 539M 16.53M 14.78M 13.67M 12.38M 23.17M 1.57B 23.55M 165M 65.09M 822M 62.03M 60.71M 2.6B P/E 2024
-3.97x
P/E 2025 -12.2x
Enterprise Value 568M 17.42M 15.58M 14.41M 13.05M 24.42M 1.66B 24.82M 173M 68.61M 867M 65.39M 63.99M 2.74B EV / Sales 2024
33.7x
EV / Sales 2025 5.13x
Free-Float
64.34%
Yield 2024 *
-
Yield 2025 -
3 years 2.27
Extreme 2.27
6.48
5 years 2.27
Extreme 2.27
6.48
10 years 1.89
Extreme 1.89
8.54
Manager TitleAgeSince
Chief Executive Officer - 17/08/2022
Director of Finance/CFO - 10/06/2022
Corporate Officer/Principal - 10/06/2022
Director TitleAgeSince
Director/Board Member - 10/06/2019
Chairman - 17/08/2022
Director/Board Member - 10/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-9.85%-.--%-.--%+32.22% 16.53M
+0.47%+0.00%-18.18%+10.73% 179B
-0.93%+2.06%-20.75%+17.60% 118B
-0.97%+1.74%+0.27%+34.12% 117B
-3.42%+15.09%-44.71%+5.61% 93.26B
-0.34%-3.05%-1.91%+74.78% 63.16B
+0.04%+1.79%+13.52%+75.53% 55.68B
-1.95%+2.26%+4.29%-23.26% 54.18B
+1.62%+2.45%-12.05%+43.27% 44.15B
+0.03%+6.23%-4.20%-7.53% 33.95B
Average -1.52%+0.80%-8.37%+26.31% 75.84B
Weighted average by Cap. -0.67%+3.05%-12.73%+23.51%

Financials

2024 2025
Net sales 15.47M 474K 424K 393K 355K 665K 45.14M 676K 4.72M 1.87M 23.61M 1.78M 1.74M 74.76M 111M 3.4M 3.04M 2.81M 2.54M 4.76M 323M 4.84M 33.81M 13.37M 169M 12.75M 12.47M 535M
Net income -134M -4.1M -3.67M -3.4M -3.07M -5.75M -391M -5.85M -40.86M -16.16M -204M -15.41M -15.08M -647M -44.02M -1.35M -1.21M -1.12M -1.01M -1.89M -128M -1.92M -13.44M -5.32M -67.2M -5.07M -4.96M -213M
Net Debt -16.95M -520K -465K -430K -390K -729K -49.48M -741K -5.18M -2.05M -25.88M -1.95M -1.91M -81.95M 29.12M 893K 799K 739K 669K 1.25M 84.99M 1.27M 8.89M 3.52M 44.46M 3.35M 3.28M 141M
Projected Income Statement - Annual - Lead Data Inc.
Logo Lead Data Inc.
Lead Data Inc is a Taiwan-based company principally engaged in the trading business of medical equipment. The Company’s main products include continuous positive airway pressures (CPAP), hearing aids, oxygen concentrators, oxygen concentrators and rapid screening reagents for novel coronavirus pneumonia (COVID-19). CPAP can treat obstructive sleep apnea. It also has great benefits in improving sleep quality and solving snoring problems. The Company mainly operates in Taiwan and mainland China.
Employees
-
  1. Stock Market
  2. Stocks
  3. 2443 Stock